Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Hay

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
A direction for Value in HealthJ W Hay, R L Ernst
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Introduction to the ISPOR Lipid ConferenceJ W Hay, J S Schwartz
Lancet (London, England)|July 12, 1986
Rand Health Insurance studyJ W Hay, R Ricardo-Campbell
American Journal of Public Health|September 1, 1987
The economic costs of Alzheimer's diseaseJ W Hay, R L Ernst
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" marketJ W Hay, W M Yu
The Pediatric Infectious Disease Journal|April 1, 1990
Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of ageJ W Hay, R S Daum
Clinical Therapeutics|January 1, 1985
Cost-effectiveness of two transdermal nitroglycerin controlled-release systemsJ W Hay, W L Hill
The American Journal of Cardiology|January 15, 1996
Cost of lipid-lowering statin drugsA M Gotto, J W Hay
American Journal of Public Health|April 1, 1991
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary diseaseJ W Hay, E D Robin
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
The ISPOR Lipid Conference: pharmacoeconomics and outcomes modeling issuesJ W Hay, J S Schwartz
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
A direction for Value in HealthJ W Hay, R L Ernst
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Introduction to the ISPOR Lipid ConferenceJ W Hay, J S Schwartz
Lancet (London, England)|July 12, 1986
Rand Health Insurance studyJ W Hay, R Ricardo-Campbell
American Journal of Public Health|September 1, 1987
The economic costs of Alzheimer's diseaseJ W Hay, R L Ernst
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" marketJ W Hay, W M Yu
The Pediatric Infectious Disease Journal|April 1, 1990
Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of ageJ W Hay, R S Daum
Clinical Therapeutics|January 1, 1985
Cost-effectiveness of two transdermal nitroglycerin controlled-release systemsJ W Hay, W L Hill
The American Journal of Cardiology|January 15, 1996
Cost of lipid-lowering statin drugsA M Gotto, J W Hay
American Journal of Public Health|April 1, 1991
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary diseaseJ W Hay, E D Robin
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
The ISPOR Lipid Conference: pharmacoeconomics and outcomes modeling issuesJ W Hay, J S Schwartz
Pageof 5